Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- Check3 days agoChange DetectedUpdated from v3.0.1 to v3.0.2 on 2025-09-08, adding a new 'Study Status Contacts/Locations' entry (dated 2025-09-05, with 59 items) and removing the 'Back to Top' element.SummaryDifference1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.5%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and country listings.SummaryDifference49%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has updated its version from v2.16.11 to v2.16.12, and the date has changed from July 14, 2025, to August 11, 2025.SummaryDifference1.0%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.3%
- Check46 days agoChange DetectedThe page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.